1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: MHealth Apps Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. MHealth Apps Market Revenue and Volume, By Type
8.1.1 Fitness Apps
8.1.1.1. Market Revenue and Volume Forecast
8.1.2. Lifestyle & Stress
8.1.2.1. Market Revenue and Volume Forecast
8.1.3. Nutrition & Diet
8.1.3.1. Market Revenue and Volume Forecast
8.1.4. Medical Apps
8.1.4.1. Market Revenue and Volume Forecast
8.1.5. Disease Management Apps
8.1.5.1. Market Revenue and Volume Forecast
8.1.6. Remote Monitoring Apps
8.1.6.1. Market Revenue and Volume Forecast
8.1.7. Women’s Health Apps
8.1.7.1. Market Revenue and Volume Forecast
8.1.8. Healthcare Providers/Payers
8.1.8.1. Market Revenue and Volume Forecast
8.1.9. Others
8.1.9.1. Market Revenue and Volume Forecast
9.1. MHealth Apps Market Revenue and Volume, By Platform
9.1.1. iOS
9.1.1.1. Market Revenue and Volume Forecast
9.1.2. Android
9.1.2.1. Market Revenue and Volume Forecast
10.1. North America
10.1.1. Market Revenue and Volume Forecast, By Type
10.1.2. Market Revenue and Volume Forecast, By Platform
10.1.3. U.S.
10.1.3.1. Market Revenue and Volume Forecast, By Type
10.1.3.2. Market Revenue and Volume Forecast, By Platform
10.1.4. Rest of North America
10.1.4.1. Market Revenue and Volume Forecast, By Type
10.1.4.2. Market Revenue and Volume Forecast, By Platform
10.2. Europe
10.2.1. Market Revenue and Volume Forecast, By Type
10.2.2. Market Revenue and Volume Forecast, By Platform
10.2.3. UK
10.2.3.1. Market Revenue and Volume Forecast, By Type
10.2.3.2. Market Revenue and Volume Forecast, By Platform
10.2.4. Germany
10.2.4.1. Market Revenue and Volume Forecast, By Type
10.2.4.2. Market Revenue and Volume Forecast, By Platform
10.2.5. France
10.2.5.1. Market Revenue and Volume Forecast, By Type
10.2.5.2. Market Revenue and Volume Forecast, By Platform
10.2.6. Rest of Europe
10.2.6.1. Market Revenue and Volume Forecast, By Type
10.2.6.2. Market Revenue and Volume Forecast, By Platform
10.3. APAC
10.3.1. Market Revenue and Volume Forecast, By Type
10.3.2. Market Revenue and Volume Forecast, By Platform
10.3.3. India
10.3.3.1. Market Revenue and Volume Forecast, By Type
10.3.3.2. Market Revenue and Volume Forecast, By Platform
10.3.4. China
10.3.4.1. Market Revenue and Volume Forecast, By Type
10.3.4.2. Market Revenue and Volume Forecast, By Platform
10.3.5. Japan
10.3.5.1. Market Revenue and Volume Forecast, By Type
10.3.5.2. Market Revenue and Volume Forecast, By Platform
10.3.6. Rest of APAC
10.3.6.1. Market Revenue and Volume Forecast, By Type
10.3.6.2. Market Revenue and Volume Forecast, By Platform
10.4. MEA
10.4.1. Market Revenue and Volume Forecast, By Type
10.4.2. Market Revenue and Volume Forecast, By Platform
10.4.3. GCC
10.4.3.1. Market Revenue and Volume Forecast, By Type
10.4.3.2. Market Revenue and Volume Forecast, By Platform
10.4.4. North Africa
10.4.4.1. Market Revenue and Volume Forecast, By Type
10.4.4.2. Market Revenue and Volume Forecast, By Platform
10.4.5. South Africa
10.4.5.1. Market Revenue and Volume Forecast, By Type
10.4.5.2. Market Revenue and Volume Forecast, By Platform
10.4.6. Rest of MEA
10.4.6.1. Market Revenue and Volume Forecast, By Type
10.4.6.2. Market Revenue and Volume Forecast, By Platform
10.5. Latin America
10.5.1. Market Revenue and Volume Forecast, By Type
10.5.2. Market Revenue and Volume Forecast, By Platform
10.5.3. Brazil
10.5.3.1. Market Revenue and Volume Forecast, By Type
10.5.3.2. Market Revenue and Volume Forecast, By Platform
10.5.4. Rest of LATAM
10.5.4.1. Market Revenue and Volume Forecast, By Type
10.5.4.2. Market Revenue and Volume Forecast, By Platform
11.1. Abbott Laboratories
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. Johnson and Johnson
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. AstraZeneca PLC
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. Hoffmann-La Roche Ltd.
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. Novartis AG
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. Bristol-Myers Squibb Company
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. GlaxoSmithKline plc
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. Merck and Co., Inc.
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. Pfizer, Inc.
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
11.10. iHealth Labs Inc.
11.10.1. Company Overview
11.10.2. Product Offerings
11.10.3. Financial Performance
11.10.4. Recent Initiatives
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
13.1. About Us
13.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
